{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:15:19Z","timestamp":1790741719967,"version":"4.1.0"},"reference-count":55,"publisher":"The Endocrine Society","issue":"4","license":[{"start":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T00:00:00Z","timestamp":1726531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2020081\/2020"],"award-info":[{"award-number":["2020081\/2020"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research Council of Norway INFRASTRUKTUR-program","award":["295910"],"award-info":[{"award-number":["295910"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Context<\/jats:title>\n                    <jats:p>Silent corticotroph adenoma (SCA) exhibits more tumor aggressiveness features than functioning adenomas (FCAs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>We aimed to investigate proprotein convertase subtilisin\/kexin type 1 inhibitor (PCSK1N) expression in CA and examine if endoplasmic reticulum (ER) stress-induced responses affect cell survival in a corticotroph tumor cell model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Clinical and imaging characteristics were recorded in 33 patients with FCA (20 women, 11 macroadenomas) and 18 SCAs (8 women, all macroadenomas). Gene expression of pro-opiomelanocortin (POMC), T-box transcription factor 19(TBX19)\/TPIT, proprotein convertase subtilisin\/kexin type 1 (PCSK1)\/PC1\/3, and its inhibitor PCSK1N, was measured by reverse transcription\u2013quantitative polymerase chain reaction in adenoma tissue. Mouse pituitary corticotroph tumor (AtT-20) cells were treated with tanespimycin (17-AAG), an HSP90 chaperone inhibitor, to induce ER stress, followed by gene and protein analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>POMC, TPIT, and PCSK1 expression were higher, whereas PCSK1N was lower in FCA compared to SCA. PCSK1N correlated with POMC (rs = \u22120.514; P &amp;lt; .001), TPIT (rs = \u22120.386; P = .005), PCSK1 (rs = \u22120.3691; P = .008), and tumor largest diameter (rs = 0.645; P &amp;lt; .001), in all CA. Induction of ER stress by 17-AAG in AtT-20 cells led to a decrease of Pomc and an increase of Pcsk1n gene expression at 24\u2005hours. Moreover, a downregulation of cell cycle, apoptosis, and senescence pathways, and alterations in cell adhesion and cytoskeleton, were observed at the protein level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>PCSK1N is higher in SCA compared with FCA, and associated with corticotroph cell markers and tumor size. PCSK1N is likely to be part of the adaptive response to ER stress, potentially conferring a survival advantage to the corticotroph tumor cell in conjunction with other proteins.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgae643","type":"journal-article","created":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T08:56:27Z","timestamp":1726476987000},"page":"1065-1075","source":"Crossref","is-referenced-by-count":9,"title":["PCSK1N as a Tumor Size Marker and an ER Stress Response Protein in Corticotroph Pituitary Adenomas"],"prefix":"10.1210","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-8460-9117","authenticated-orcid":false,"given":"Merisa","family":"Abusdal","sequence":"first","affiliation":[{"name":"Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital (OUS) , 0424 Oslo ,","place":["Norway"]},{"name":"Research Institute of Internal Medicine, OUS , 0424 Oslo ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , 0318 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjersti R","family":"Normann","sequence":"additional","affiliation":[{"name":"Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital (OUS) , 0424 Oslo ,","place":["Norway"]},{"name":"Research Institute of Internal Medicine, OUS , 0424 Oslo ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , 0318 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8787-5886","authenticated-orcid":false,"given":"Tuula A","family":"Nyman","sequence":"additional","affiliation":[{"name":"Department of Immunology, OUS and University of Oslo , 0424 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3147-6007","authenticated-orcid":false,"given":"Kristin A B","family":"\u00d8ystese","sequence":"additional","affiliation":[{"name":"Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital (OUS) , 0424 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3007-7784","authenticated-orcid":false,"given":"Arvind Y M","family":"Sundaram","sequence":"additional","affiliation":[{"name":"Department of Medical Genetics, OUS and University of Oslo , 0424 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5278-1978","authenticated-orcid":false,"given":"Daniel","family":"Dahlberg","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, OUS , 0424 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7962-4726","authenticated-orcid":false,"given":"Tove","family":"Lekva","sequence":"additional","affiliation":[{"name":"Research Institute of Internal Medicine, OUS , 0424 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0654-4610","authenticated-orcid":false,"given":"Jens","family":"Bollerslev","sequence":"additional","affiliation":[{"name":"Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital (OUS) , 0424 Oslo ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , 0318 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0157-5888","authenticated-orcid":false,"given":"Jens P","family":"Berg","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , 0318 Oslo ,","place":["Norway"]},{"name":"Department of Medical Biochemistry, OUS , 0424 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-9436-539X","authenticated-orcid":false,"given":"Nicoleta C","family":"Olarescu","sequence":"additional","affiliation":[{"name":"Section of Specialized Endocrinology, Department of Endocrinology, Oslo University Hospital (OUS) , 0424 Oslo ,","place":["Norway"]},{"name":"Research Institute of Internal Medicine, OUS , 0424 Oslo ,","place":["Norway"]},{"name":"Institute of Clinical Medicine, Faculty of Medicine, University of Oslo , 0318 Oslo ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2024,9,17]]},"reference":[{"issue":"1","key":"2025031717092000700_dgae643-B1","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"issue":"7","key":"2025031717092000700_dgae643-B2","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1210\/jc.2018-00688","article-title":"Clinical and pathological aspects of silent pituitary adenomas","volume":"104","author":"Drummond","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2025031717092000700_dgae643-B3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s11102-018-0864-8","article-title":"Silent corticotroph adenomas","volume":"21","author":"Ben-Shlomo","year":"2018","journal-title":"Pituitary"},{"issue":"6","key":"2025031717092000700_dgae643-B4","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2016-4061","article-title":"Outcome of nonfunctioning pituitary adenomas that regrow after primary treatment: a study from two large UK centers","volume":"102","author":"Tampourlou","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"2025031717092000700_dgae643-B5","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41574-021-00550-w","article-title":"Aggressive pituitary tumours and pituitary carcinomas","volume":"17","author":"Raverot","year":"2021","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"2025031717092000700_dgae643-B6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11102-023-01310-x","article-title":"TGFBR3L is associated with gonadotropin production in non-functioning gonadotroph pituitary neuroendocrine tumours","volume":"26","author":"Kolnes","year":"2023","journal-title":"Pituitary"},{"issue":"2","key":"2025031717092000700_dgae643-B7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ando.2012.03.039","article-title":"Prevalence and incidence of pituitary adenomas","volume":"73","author":"Karavitaki","year":"2012","journal-title":"Ann Endocrinol (Paris)"},{"issue":"1","key":"2025031717092000700_dgae643-B8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0090-3019(98)00013-5","article-title":"Large and invasive silent corticotroph-cell adenoma with elevated serum ACTH: a case report","volume":"50","author":"Ueyama","year":"1998","journal-title":"Surg Neurol"},{"issue":"4","key":"2025031717092000700_dgae643-B9","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1152\/physrev.00024.2017","article-title":"POMC: the physiological power of hormone processing","volume":"98","author":"Harno","year":"2018","journal-title":"Physiol Rev"},{"issue":"4","key":"2025031717092000700_dgae643-B10","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1023\/A:1025321731790","article-title":"Significance of absent prohormone convertase 1\/3 in inducing clinically silent corticotroph pituitary adenoma of subtype I\u2013immunohistochemical study","volume":"5","author":"Ohta","year":"2002","journal-title":"Pituitary"},{"issue":"2","key":"2025031717092000700_dgae643-B11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1007\/s12020-016-1028-0","article-title":"The changing faces of corticotroph cell adenomas: the role of prohormone convertase 1\/3","volume":"56","author":"Righi","year":"2017","journal-title":"Endocrine"},{"issue":"31","key":"2025031717092000700_dgae643-B12","doi-asserted-by":"crossref","first-page":"23596","DOI":"10.1074\/jbc.M001583200","article-title":"The C-terminal region of proSAAS is a potent inhibitor of prohormone convertase 1","volume":"275","author":"Qian","year":"2000","journal-title":"J Biol Chem"},{"issue":"35","key":"2025031717092000700_dgae643-B13","doi-asserted-by":"crossref","first-page":"32720","DOI":"10.1074\/jbc.M104064200","article-title":"Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1","volume":"276","author":"Basak","year":"2001","journal-title":"J Biol Chem"},{"issue":"10","key":"2025031717092000700_dgae643-B14","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.3390\/cancers12102980","article-title":"Distinct pattern of endoplasmic reticulum protein processing and extracellular matrix proteins in functioning and silent corticotroph pituitary adenomas","volume":"12","author":"Eieland","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"6","key":"2025031717092000700_dgae643-B15","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr Rev"},{"issue":"1","key":"2025031717092000700_dgae643-B16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1530\/EJE-21-1183","article-title":"Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior","volume":"187","author":"Zhang","year":"2022","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2025031717092000700_dgae643-B17","doi-asserted-by":"crossref","first-page":"100934","DOI":"10.1016\/j.xcrm.2023.100934","article-title":"Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET","volume":"4","author":"Zhang","year":"2023","journal-title":"Cell Rep Med"},{"issue":"8","key":"2025031717092000700_dgae643-B18","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.molcel.2022.03.025","article-title":"Reshaping endoplasmic reticulum quality control through the unfolded protein response","volume":"82","author":"Wiseman","year":"2022","journal-title":"Mol Cell"},{"issue":"6","key":"2025031717092000700_dgae643-B19","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1007\/s12192-020-01128-7","article-title":"Increased expression and retention of the secretory chaperone proSAAS following cell stress","volume":"25","author":"Shakya","year":"2020","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"2025031717092000700_dgae643-B20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.3390\/ijms22010004","article-title":"Thapsigargin-from traditional medicine to anticancer drug","volume":"22","author":"Jaskulska","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"1","key":"2025031717092000700_dgae643-B21","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1158\/1078-0432.CCR-11-1000","article-title":"Hsp90 molecular chaperone inhibitors: are we there yet?","volume":"18","author":"Neckers","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"7","key":"2025031717092000700_dgae643-B22","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1182\/blood-2006-11-053728","article-title":"Heat shock protein inhibition is associated with activation of the unfolded protein response pathway in myeloma plasma cells","volume":"110","author":"Davenport","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2025031717092000700_dgae643-B23","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bcp.2009.04.001","article-title":"Hsp90 inhibitors, GA and 17AAG, lead to ER stress-induced apoptosis in rat histiocytoma","volume":"78","author":"Taiyab","year":"2009","journal-title":"Biochem Pharmacol"},{"issue":"1","key":"2025031717092000700_dgae643-B24","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12020-012-9871-0","article-title":"Different levels of various glucocorticoid-regulated genes in corticotroph adenomas","volume":"44","author":"Evang","year":"2013","journal-title":"Endocrine"},{"issue":"1","key":"2025031717092000700_dgae643-B25","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s12020-022-03051-6","article-title":"Distribution of E- and N-cadherin in subgroups of non-functioning pituitary neuroendocrine tumours","volume":"77","author":"\u00d8ystese","year":"2022","journal-title":"Endocrine"},{"issue":"4","key":"2025031717092000700_dgae643-B26","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00401-017-1768-9","article-title":"A specific antibody to detect transcription factor T-Pit: a reliable marker of corticotroph cell differentiation and a tool to improve the classification of pituitary neuroendocrine tumours","volume":"134","author":"Sj\u00f6stedt","year":"2017","journal-title":"Acta Neuropathol"},{"issue":"9","key":"2025031717092000700_dgae643-B27","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1210\/jc.2017-00792","article-title":"Estrogen receptor \u03b1, a sex-dependent predictor of aggressiveness in nonfunctioning pituitary adenomas: SSTR and sex hormone receptor distribution in NFPA","volume":"102","author":"\u00d8ystese","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2025031717092000700_dgae643-B28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.mce.2016.08.030","article-title":"Selection and validation of reliable reference genes for RT-qPCR analysis in a large cohort of pituitary adenomas","volume":"437","author":"Normann","year":"2016","journal-title":"Mol Cell Endocrinol"},{"issue":"suppl_1","key":"2025031717092000700_dgae643-B29","doi-asserted-by":"crossref","first-page":"D792","DOI":"10.1093\/nar\/gkp1005","article-title":"PrimerBank: a resource of human and mouse PCR primer pairs for gene expression detection and quantification","volume":"38","author":"Spandidos","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"2025031717092000700_dgae643-B30","unstructured":"Abusdal M, Nyman T, Olarescu N. JCEM Supplementary files\u2014Primers and DEPs. Dryad Digital Repository. doi:10.5061\/dryad.stqjq2c9n. Accessed 5 April 2024."},{"issue":"5","key":"2025031717092000700_dgae643-B31","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1074\/mcp.TIR118.001270","article-title":"Protein aggregation capture on microparticles enables multipurpose proteomics sample preparation","volume":"18","author":"Batth","year":"2019","journal-title":"Mol Cell Proteomics"},{"issue":"5","key":"2025031717092000700_dgae643-B32","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1507\/endocrj.K07-059","article-title":"Defective expression of prohormone convertase 1\/3 in silent corticotroph adenoma","volume":"54","author":"Tateno","year":"2007","journal-title":"Endocr J"},{"issue":"5","key":"2025031717092000700_dgae643-B33","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3233\/JPD-213053","article-title":"The proSAAS chaperone provides neuroprotection and attenuates transsynaptic \u03b1-synuclein spread in rodent models of Parkinson's disease","volume":"12","author":"Lindberg","year":"2022","journal-title":"Journal of Parkinson's Disease"},{"issue":"5","key":"2025031717092000700_dgae643-B34","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1210\/en.2011-2019","article-title":"Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets","volume":"153","author":"Alarcon","year":"2012","journal-title":"Endocrinology"},{"issue":"32","key":"2025031717092000700_dgae643-B35","doi-asserted-by":"crossref","first-page":"E4708","DOI":"10.1073\/pnas.1601091113","article-title":"The neural chaperone proSAAS blocks \u03b1-synuclein fibrillation and neurotoxicity","volume":"113","author":"Jarvela","year":"2016","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"2025031717092000700_dgae643-B36","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/jnc.12454","article-title":"A novel function for proSAAS as an amyloid anti-aggregant in Alzheimer's disease","volume":"128","author":"Hoshino","year":"2014","journal-title":"J Neurochem"},{"issue":"1","key":"2025031717092000700_dgae643-B37","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12967-021-02786-6","article-title":"GRP78 in lung cancer","volume":"19","author":"Xia","year":"2021","journal-title":"J Transl Med"},{"issue":"2","key":"2025031717092000700_dgae643-B38","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41419-019-1408-5","article-title":"ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining \u201cstemness\u201d","volume":"10","author":"Dauer","year":"2019","journal-title":"Cell Death Dis"},{"issue":"8","key":"2025031717092000700_dgae643-B39","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bbamcr.2006.10.001","article-title":"Roles of the Raf\/MEK\/ERK pathway in cell growth, malignant transformation and drug resistance","volume":"1773","author":"McCubrey","year":"2007","journal-title":"Biochim Biophys Acta"},{"issue":"9","key":"2025031717092000700_dgae643-B40","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1158\/1535-7163.MCT-08-0172","article-title":"Glucose-regulated protein 78 regulates multiple malignant phenotypes in head and neck cancer and may serve as a molecular target of therapeutic intervention","volume":"7","author":"Chiu","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"2025031717092000700_dgae643-B41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.biocel.2015.04.012","article-title":"Overexpressed GRP78 affects EMT and cell-matrix adhesion via autocrine TGF-\u03b2\/Smad2\/3 signaling","volume":"64","author":"Zhang","year":"2015","journal-title":"Int J Biochem Cell Biol"},{"issue":"6","key":"2025031717092000700_dgae643-B42","doi-asserted-by":"crossref","first-page":"8219","DOI":"10.1007\/s13277-015-4669-3","article-title":"Glucose-regulated protein 94 mediates metastasis by CCT8 and the JNK pathway in hepatocellular carcinoma","volume":"37","author":"Wei","year":"2016","journal-title":"Tumour Biol"},{"key":"2025031717092000700_dgae643-B43","doi-asserted-by":"crossref","first-page":"629846","DOI":"10.3389\/fonc.2021.629846","article-title":"Molecular chaperone GRP94\/GP96 in cancers: oncogenesis and therapeutic target","volume":"11","author":"Duan","year":"2021","journal-title":"Front Oncol"},{"issue":"3","key":"2025031717092000700_dgae643-B44","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/1759-7714.13321","article-title":"Overexpression of molecule GRP94 favors tumor progression in lung adenocarcinoma by interaction with regulatory T cells","volume":"11","author":"Duan","year":"2020","journal-title":"Thorac Cancer"},{"issue":"17","key":"2025031717092000700_dgae643-B45","doi-asserted-by":"crossref","first-page":"5943","DOI":"10.1158\/0008-5472.CAN-04-1606","article-title":"XBP1 is essential for survival under hypoxic conditions and is required for tumor growth","volume":"64","author":"Romero-Ramirez","year":"2004","journal-title":"Cancer Res"},{"issue":"3","key":"2025031717092000700_dgae643-B46","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2478\/s11658-013-0096-x","article-title":"Transcriptional regulation of mouse mesencephalic astrocyte-derived neurotrophic factor in Neuro2a cells","volume":"18","author":"Oh-Hashi","year":"2013","journal-title":"Cell Mol Biol Lett"},{"issue":"5","key":"2025031717092000700_dgae643-B47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/embor.2008.37","article-title":"Synoviolin promotes IRE1 ubiquitination and degradation in synovial fibroblasts from mice with collagen-induced arthritis","volume":"9","author":"Gao","year":"2008","journal-title":"EMBO Rep"},{"issue":"4","key":"2025031717092000700_dgae643-B48","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.molcel.2014.01.004","article-title":"Protein disulfide isomerase A6 controls the decay of IRE1\u03b1 signaling via disulfide-dependent association","volume":"53","author":"Eletto","year":"2014","journal-title":"Mol Cell"},{"issue":"37","key":"2025031717092000700_dgae643-B49","doi-asserted-by":"crossref","first-page":"16113","DOI":"10.1073\/pnas.1010580107","article-title":"Mammalian endoplasmic reticulum stress sensor IRE1 signals by dynamic clustering","volume":"107","author":"Li","year":"2010","journal-title":"Proc Natl Acad Sci"},{"issue":"48","key":"2025031717092000700_dgae643-B50","doi-asserted-by":"crossref","first-page":"49689","DOI":"10.1074\/jbc.C400261200","article-title":"Protein-tyrosine phosphatase 1B potentiates IRE1 signaling during endoplasmic reticulum stress*","volume":"279","author":"Gu","year":"2004","journal-title":"J Biol Chem"},{"issue":"9","key":"2025031717092000700_dgae643-B51","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1007\/s12035-022-02954-9","article-title":"Ubiquitous neural cell adhesion molecule (NCAM): potential mechanism and valorisation in cancer pathophysiology, drug targeting and molecular transductions","volume":"59","author":"Sowparani","year":"2022","journal-title":"Mol Neurobiol"},{"issue":"3-4","key":"2025031717092000700_dgae643-B52","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000313699","article-title":"Effect of human colorectal carcinogenesis on the neural cell adhesion molecule expression and polysialylation","volume":"78","author":"Fern\u00e1ndez-Briera","year":"2010","journal-title":"Oncology"},{"key":"2025031717092000700_dgae643-B53","doi-asserted-by":"crossref","first-page":"319589","DOI":"10.1155\/2015\/319589","article-title":"A comprehensive systems biological study of autophagy-apoptosis crosstalk during endoplasmic reticulum stress","volume":"2015","author":"Holczer","year":"2015","journal-title":"Biomed Res Int"},{"issue":"6","key":"2025031717092000700_dgae643-B54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nrendo.2014.35","article-title":"Autophagy\u2014a key player in cellular and body metabolism","volume":"10","author":"Kim","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"12","key":"2025031717092000700_dgae643-B55","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1080\/10715762.2016.1253073","article-title":"P62\/SQSTM1 is required for the protection against endoplasmic reticulum stress-induced apoptotic cell death","volume":"50","author":"Park","year":"2016","journal-title":"Free Radic Res"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgae643\/59341003\/dgae643.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/1065\/59341003\/dgae643.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/110\/4\/1065\/59341003\/dgae643.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T13:09:51Z","timestamp":1742216991000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/110\/4\/1065\/7759353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,17]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,9,17]]},"published-print":{"date-parts":[[2025,3,17]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgae643","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,4]]},"published":{"date-parts":[[2024,9,17]]}}}